X4 Pharmaceuticals, Inc. (XFOR)

NASDAQ: XFOR · Real-Time Price · USD

3.980

-0.020 (-0.50%)

At close: Jul 31, 2026, 4:00 PM EDT

3.970

-0.010 (-0.25%)

After-hours: Jul 31, 2026, 7:34 PM EDT

X4 Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	375	364	125	140	121	64
Market Cap Growth	3268.80%	189.93%	-10.69%	16.23%	87.57%	-38.56%
Enterprise Value	218.93	187.91	101.44	84.49	37.52	22.41
Last Close Price	3.98	4.00	22.01	25.16	29.79	68.70

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	41.65	10.36	49.05	-	-	-
PB Ratio	2.23	1.95	5.66	2.75	1.63	1.00
P/TBV Ratio	2.02	1.06	-	4.42	1.12	1.25

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	24.29	5.35	39.67	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.45	0.41	3.47	1.12	0.49	0.59
Net Debt / Equity Ratio	-0.93	-0.94	-1.08	-1.09	-1.13	-0.65
Net Debt / EBITDA Ratio	1.62	2.05	0.10	0.52	0.95	0.50
Net Debt / FCF Ratio	1.69	2.05	0.18	0.58	1.08	0.59
Asset Turnover	0.03	0.16	0.02	0	0	0
Inventory Turnover	0.36	1.58	0.57	-	-	-
Quick Ratio	9.88	9.84	3.16	5.02	5.50	5.89
Current Ratio	10.18	10.16	3.41	5.34	5.76	6.27
Return on Equity (ROE)	-56.22%	-75.99%	-102.26%	-161.83%	-135.70%	-129.30%
Return on Assets (ROA)	-34.87%	-39.79%	-169.19%	-71.06%	-64.97%	-70.92%
Return on Invested Capital (ROIC)	-866.60%	-1986.47%	-	-	-1358.99%	-309.92%
Return on Capital Employed (ROCE)	-38.24%	-45.94%	-207.09%	-83.46%	-74.94%	-79.51%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Buyback Yield / Dilution	-968.53%	-531.04%	-13.08%	-179.91%	-146.71%	-28.25%
Total Shareholder Return	-968.53%	-531.04%	-13.08%	-179.91%	-146.71%	-28.25%

SEC Filings: 10-K · 10-Q